Federation Des Caisses Desjardins Du Quebec Danaher Corp Transaction History

Federation Des Caisses Desjardins Du Quebec

$17.5 Billion
Q2 2024

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Danaher Corp stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 120,101 shares of DHR stock, worth $29.2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

120,101

Previous 144,814 17.07%

Holding current value

$29.2 Million

Previous $34.7 Billion 99.91%

% of portfolio

0.17%

Previous 0.25%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$235.51 - $267.98 $5.82 Million - $6.62 Million	-24,713 Reduced 17.07%	120,101 $30 Million
Q1 2024 May 15, 2024	BUY	$224.58 - $256.19 $32.5 Million - $37.1 Million	144,814 New	144,814 $34.7 Billion
Q4 2023 Aug 14, 2024	BUY	$185.1 - $233.13 $1.24 Million - $1.56 Million	6,674 Added 5.11%	137,287 $31.8 Billion
Q3 2023 Aug 14, 2024	BUY	$233.08 - $265.59 $291,116 - $331,721	1,249 Added 0.97%	130,613 $32.4 Billion
Q2 2023 Aug 14, 2024	BUY	$224.99 - $256.14 $7.92 Million - $9.02 Million	35,216 Added 37.4%	129,364 $31 Billion
Q1 2023 Aug 14, 2024	SELL	$239.75 - $277.0 $5.22 Million - $6.04 Million	-21,791 Reduced 18.8%	94,148 $23.7 Billion
Q4 2022 Aug 14, 2024	BUY	$241.42 - $282.29 $412,345 - $482,151	1,708 Added 1.5%	115,939 $30.8 Billion
Q3 2022 Aug 14, 2024	SELL	$247.06 - $1507.4 $535,873 - $3.27 Million	-2,169 Reduced 1.86%	114,231 $29.5 Billion
Q2 2022 Aug 14, 2024	BUY	$237.11 - $299.66 $216,955 - $274,188	915 Added 0.79%	116,400 $29.5 Billion
Q1 2022 Aug 14, 2024	SELL	$257.27 - $315.76 $1.19 Million - $1.46 Million	-4,616 Reduced 3.84%	115,485 $33.9 Billion
Q4 2021 Aug 30, 2024	BUY	$292.08 - $329.01 $5.73 Million - $6.46 Million	19,626 Added 32.69%	79,661 $26.2 Billion
Q3 2021 Aug 30, 2024	BUY	$272.21 - $332.43 $330,190 - $403,237	1,213 Added 2.06%	60,035 $18.3 Billion
Q2 2021 Aug 30, 2024	SELL	$225.08 - $271.69 $13.8 Million - $16.6 Million	-61,279 Reduced 51.02%	58,822 $15.8 Billion
Q1 2021 Aug 30, 2024	BUY	$212.38 - $245.9 $7.06 Million - $8.17 Million	33,244 Added 177.3%	51,994 $11.7 Billion
Q4 2020 Aug 30, 2024	SELL	$212.5 - $245.46 $8.88 Million - $10.3 Million	-41,780 Reduced 69.02%	18,750 $4.17 Billion
Q3 2020 Aug 30, 2024	BUY	$177.16 - $215.33 $84,682 - $102,927	478 Added 0.8%	60,530 $13 Billion
Q2 2020 Aug 30, 2024	BUY	$128.7 - $176.83 $6.74 Million - $9.26 Million	52,363 Added 681.01%	60,052 $10.6 Billion
Q1 2020 Aug 30, 2024	SELL	$121.39 - $169.05 $23,185 - $32,288	-191 Reduced 2.42%	7,689 $1.06 Billion
Q4 2019 Aug 30, 2024	BUY	$133.47 - $153.48 $189,660 - $218,095	1,421 Added 22.0%	7,880 $1.21 Billion
Q3 2019 Aug 30, 2024	BUY	$135.4 - $146.47 $438,560 - $474,416	3,239 Added 100.59%	6,459 $933 Million
Q2 2019 Aug 30, 2024	BUY	$124.88 - $143.73 $18,107 - $20,840	145 Added 4.72%	3,220 $460 Million
Q1 2019 Aug 30, 2024	SELL	$97.62 - $132.29 $1,952 - $2,645	-20 Reduced 0.65%	3,075 $406 Million
Q4 2018 Aug 30, 2024	SELL	$94.85 - $109.54 $11.1 Million - $12.8 Million	-117,006 Reduced 97.42%	3,095 $319 Million
Q3 2018 Aug 30, 2024	SELL	$98.13 - $108.9 $11,775 - $13,068	-120 Reduced 3.46%	3,350 $364 Million
Q2 2018 Aug 30, 2024	SELL	$96.1 - $103.24 $66,309 - $71,235	-690 Reduced 16.59%	3,470 $342 Million
Q1 2018 Aug 30, 2024	SELL	$92.16 - $103.8 $87,552 - $98,610	-950 Reduced 18.59%	4,160 $407 Million
Q4 2017 Aug 30, 2024	SELL	$85.26 - $94.62 $273,684 - $303,730	-3,210 Reduced 38.58%	5,110 $474 Million
Q3 2017 Aug 30, 2024	SELL	$79.29 - $88.45 $5,312 - $5,926	-67 Reduced 0.8%	8,320 $714 Million
Q2 2017 Aug 30, 2024	SELL	N/A	-915 Reduced 9.84%	8,387 $708 Million
Q1 2017 Aug 30, 2024	SELL	N/A	-110,799	9,302 $796 Million

Others Institutions Holding DHR

# of Institutions

2,432

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.11M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $177B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account

Federation Des Caisses Desjardins Du Quebec Danaher Corp Transaction History